Z-LLY-FMK contains a benzyloxycarbonyl-protected leucine-leucine-tyrosine motif attached to a reactive FMK group. The peptide is used for mapping protease specificity and studying irreversible inhibition. Researchers apply it to examine aromatic pocket recognition and cleavage preferences. Its stable protective group enhances synthetic handling.
CAT No: HB00036
Z-LLY-FMK is a synthetic peptide-based inhibitor designed for research applications in the study of protease activity, particularly targeting cysteine proteases such as the cathepsin family. Structurally, it features a benzyloxycarbonyl (Z) group at the N-terminus, a tripeptide sequence (Leu-Leu-Tyr), and a fluoromethyl ketone (FMK) moiety at the C-terminus, which imparts irreversible inhibitory properties. Its selective mechanism of action and robust peptide backbone make it a valuable tool for dissecting proteolytic pathways and understanding the regulation of protease-mediated cellular processes. Researchers employ Z-LLY-FMK to probe the functional roles of specific proteases in diverse biological systems, enabling the elucidation of complex signaling networks and the identification of novel regulatory mechanisms.
Protease inhibition assays: Z-LLY-FMK is widely utilized in biochemical assays designed to measure and characterize the activity of cysteine proteases, particularly cathepsins. By irreversibly binding to the active site cysteine residue through its FMK group, the compound effectively blocks enzymatic activity, allowing researchers to quantify the contribution of targeted proteases within complex protein mixtures. This application is instrumental in validating protease specificity, screening novel inhibitors, and optimizing assay conditions for high-throughput analysis.
Cellular pathway elucidation: In cell-based studies, Z-LLY-FMK serves as a functional probe for dissecting protease-dependent signaling pathways. Its ability to permeate cell membranes and inhibit intracellular proteases enables researchers to investigate the downstream effects of protease inhibition on cellular processes such as apoptosis, autophagy, and antigen processing. By selectively modulating protease function, the compound provides insight into the molecular mechanisms governing cell fate decisions and immune responses.
Protein degradation studies: The compound is frequently employed to investigate the roles of lysosomal and cytosolic proteases in protein turnover and degradation. By inhibiting specific protease activities, researchers can analyze the stability, processing, and accumulation of substrate proteins under various experimental conditions. This approach is essential for understanding the regulation of protein quality control systems, the pathogenesis of protein aggregation disorders, and the identification of novel degradation pathways.
Protease substrate identification: Z-LLY-FMK is also used as a tool in substrate-trapping experiments, where its covalent binding to active proteases enables the capture and subsequent identification of endogenous substrates. By forming stable enzyme-inhibitor complexes, the compound facilitates the enrichment and mass spectrometric analysis of protease-substrate interactions, advancing the discovery of physiologically relevant cleavage events and expanding knowledge of protease substrate specificity.
In vitro screening platforms: The chemical stability and specificity of Z-LLY-FMK make it suitable for use in in vitro platforms designed to evaluate the efficacy of novel protease inhibitors or modulators. By providing a well-characterized benchmark inhibitor, it allows for the comparative assessment of candidate compounds, validation of screening protocols, and optimization of assay parameters. This application supports the development of new research tools and the refinement of methodologies for studying protease biology in both academic and industrial settings.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More